Table 1 The clinicopathologic characteristics of the negative ureter resection margin patients and the positive ureter resection margin patients
Clinicopathological variables | Ureter RM (-) (n = 9, 60%) | Ureter RM (+) (n = 6, 40%) | P value |
|---|---|---|---|
Median age (years, range) | 74 (68–78) | 67 (51–76) | 0.127 |
Gender | |||
Male | 9 (100%) | 6 (100%) | |
Female | 0 | 0 | |
Tumor location | 0.005 | ||
Trigone or Bladder neck | 1 (11%) | 5 (83%) | |
Other | 8 (89%) | 1 (17%) | |
Tumor stage on RC with PLND | 0.324 | ||
≤pT2 | 1 (11%) | 0 | |
pT3a | 7 (78%) | 3 (50%) | |
pT3b | 1 (11%) | 2 (33%) | |
pT4 | 0 | 1 (17%) | |
LN stage on RC with PLND | 0.435 | ||
pN0 | 6 (67%) | 2 (33%) | |
pN1 | 1 (11%) | 1 (17%) | |
pN2 | 2 (22%) | 3 (50%) | |
Ureter orifice involvement | 0.003 | ||
Absent | 7 (78%) | 0 | |
Present | 2 (22%) | 6 (100%) | |
Proportion of PUC component | 0.132 | ||
30–65 | 5 (56%) | 1 (17%) | |
66–100 | 4 (44%) | 5 (83%) | |
NAC | 0.264 | ||
Absent | 7 (78%) | 3 (50%) | |
Present | 2 (22%) | 3 (50%) | |
Progression (Metastasis) | 0.205 | ||
Absent | 6 (67%) | 2 (33%) | |
Present | 3 (33%) | 4 (67%) | |
Death | 0.634 | ||
No | 7 (78%) | 4 (67%) | |
Yes | 2 (22%) | 2 (33%) |